News

In the fight against Alzheimer's, Lion's mane mushroom shows promise. A recent study reveals that its extract can ease ...
Krystal Biotech announced the first patient has been dosed in EMERALD-1, its phase 1/2 clinical trial evaluating KB801 for the treatment of neurotrophic keratitis (NK), a degenerative corneal disease ...
Krystal Biotech climbs after dosing begins in a phase I/II trial for KB801, a gene therapy eye drop targeting neurotrophic keratitis.
Eye drop administration of KB801 designed to enable sustained expression of NGF in the front of the eye Investor call and webcast to be held July 9 at 8:30 am ET to discuss program and trial design PI ...
PITTSBURGH, July 09, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the "Company”) (NASDAQ: KRYS) announced today that the first patient has been dosed in its Phase 1/2 clinical trial ("EMERALD-1”), ...
Neuro Energizer reviews reveal my 30-day experience with this brain supplement—see real results, ingredients, benefits, ...
Members of the nerve growth factor (NGF) and glial cell line-derived neurotrophic factor (GDNF) families — comprising neurotrophins and GDNF-family ligands (GFLs), respectively — are crucial ...
A polymer-based device cleared by the FDA offers physicians a new way for repairing peripheral nerve injuries.
According to NYU Langone, more than 80% of men and nearly half of women experience hair loss at some point in their lives. But with so much info out there, figuring out which remedies are most ...